Home › Compare › RHNMF vs EQR

RHNMF vs EQR: Dividend Comparison 2026

RHNMF yields 10526.32% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RHNMF wins by $91421458538285344.00M in total portfolio value
10 years
RHNMF
RHNMF
● Live price
10526.32%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$91421458538285344.00M
Annual income
$89,744,322,218,307,970,000,000.00
Full RHNMF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — RHNMF vs EQR

📍 RHNMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRHNMFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RHNMF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RHNMF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RHNMF
Annual income on $10K today (after 15% tax)
$894,736.84/yr
After 10yr DRIP, annual income (after tax)
$76,282,673,885,561,770,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, RHNMF beats the other by $76,282,673,885,561,770,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RHNMF + EQR for your $10,000?

RHNMF: 50%EQR: 50%
100% EQR50/50100% RHNMF
Portfolio after 10yr
$45710729269142672.00M
Annual income
$44,872,161,109,153,986,000,000.00/yr
Blended yield
98.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

RHNMF
No analyst data
Altman Z
-9.5
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RHNMF buys
0
EQR buys
0
No recent congressional trades found for RHNMF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRHNMFEQR
Forward yield10526.32% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$91421458538285344.00M ✓$47.8K
Annual income after 10y$89,744,322,218,307,970,000,000.00 ✓$5,475.61
Total dividends collected$91309952364754128.00M ✓$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: RHNMF vs EQR ($10,000, DRIP)

YearRHNMF PortfolioRHNMF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$1,063,332$1,052,631.58$11,380$679.82+$1.05M → RHNMF
2$105,744,905$104,607,140.08$13,014$837.25+$105.73M → RHNMF
3$9,835,430,757$9,722,283,708.79$14,961$1,036.20+$9835.42M → RHNMF
4$855,644,041,989$845,120,131,078.84$17,297$1,289.22+$855644.02M → RHNMF
5$69,627,827,846,009$68,712,288,721,080.95$20,121$1,613.15+$69627827.83M → RHNMF
6$5,300,152,192,813,391$5,225,650,417,018,161.00$23,561$2,030.84+$5300152192.79M → RHNMF
7$377,430,657,448,967,200$371,759,494,602,656,830.00$27,783$2,573.54+$377430657448.94M → RHNMF
8$25,145,413,383,015,215,000$24,741,562,579,544,820,000.00$33,013$3,284.39+$25145413383015.18M → RHNMF
9$1,567,417,121,474,185,500,000$1,540,511,529,154,359,300,000.00$39,547$4,223.51+$1567417121474185.50M → RHNMF
10$91,421,458,538,285,340,000,000$89,744,322,218,307,970,000,000.00$47,791$5,475.61+$91421458538285344.00M → RHNMF

RHNMF vs EQR: Complete Analysis 2026

RHNMF — Stock

Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is headquartered in Cremorne, Australia.

Full RHNMF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this RHNMF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RHNMF vs SCHDRHNMF vs JEPIRHNMF vs ORHNMF vs KORHNMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.